Scan Me!
Scientists believe they have improved a tool used to predict how someone will react to weight loss surgery and the probability of putting their type 2 diabetes into remission. At the moment doctors use a standard scoring system called DiaRem which combines the person’s age, body mass index (BMI), diabetes indicators and treatments to determine potential health outcomes after weight loss surgery.
Source: Improvements made to type 2 diabetes remission tool used in weight loss surgery
Diabetes Prevention Program follow-up data add support to prior observations.
Source:Statins may raise type 2 diabetes odds among adults already at risk
Type 2 diabetes is an independent risk factor for sudden cardiac arrest and death in patients with coronary artery disease with preserved ejection fraction.
Source: Type 2 Diabetes an Independent Risk Factor for Coronary Artery Disease – Endocrinology Advisor
Comparing three classes of type 2 diabetes drugs, researchers found one class, which includes Onglyza and Januvia, did not reduce death risk.
Source: Class of type 2 diabetes drugs doesn’t cut death risk compared to placebo
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors came out on top in a large meta-analysis of clinical trials that compared the newer classes of diabetes drugs head-to-head in terms of mortality, cardiovascular, and safety endpoints.
Source: SGLT-2 Inhibitors: The Best Bet Among New T2D Drugs?
Trial shows that a pill version of Ozempic (semaglutide) can lower A1c by as much as 1.5% and also support weight loss.
Source: Promising Early Study Results for the First GLP-1 Pill for Type 2 Diabetes
A large number of people diagnosed with type 2 diabetes show symptoms of chronic kidney disease (CKD) before their diabetes diagnosis, researchers report. People with diabetes face an increased risk of kidney disease, but this new study reveals kidney damage could occur much earlier than expected.
Source: Kidney disease symptoms present prior to type 2 diabetes diagnosis, study finds
Adults with type 2 diabetes who lost at least 30% of their maximum body weight had increased risks for fragility fractures and any fracture compared with those who lost less weight, according to findings published in Diabetes Care.
Source: Large weight loss raises fragility fracture risk in type 2 diabetes
Study participants achieved remission to non-diabetic state
Diabetes Webinar
Med-IQ offers this professional webinar: Expert Insights on Insulin and GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes Mellitus (Med-IQ)
Labs
Supplements
Log in
Register